These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 13601613)

  • 1. [Mechanism of the hypoglycemic action of antidiabetic sulfanilamide preparations].
    LEITES SM; SMIRNOV NP
    Probl Endokrinol Gormonoter; 1958; 4(4):3-12. PubMed ID: 13601613
    [No Abstract]   [Full Text] [Related]  

  • 2. [ON THE EFFECT OF ANTIDIABETIC SULFANILAMIDE PREPARATIONS ON FAT-LIPOID METABOLISM IN DIABETES MELLITUS].
    TRUNCHENKOVA ES
    Klin Med (Mosk); 1963 Jul; 41():63-7. PubMed ID: 14071115
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypoglycemic and antidiabetic sulfonamides. II. Study of their mechanism of action in normal and diabetic subjects].
    LOUBATIERES A
    Presse Med (1893); 1958 Jul; 66(53):1229-32. PubMed ID: 13567572
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of the liver in the mechanism of hypoglycemic action of antidiabetic sulfonamides].
    LEITES SM; SMIRNOV NP
    Biull Eksp Biol Med; 1958 Sep; 46(9):53-6. PubMed ID: 13607530
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypoglycemic action of N-3, 4-dimethylbenzoyl-sulfanilamide in normal dogs].
    GARCIA-BLANCO J; ANTON V
    Rev Esp Fisiol; 1958 Jun; 14(2):119-21. PubMed ID: 13579535
    [No Abstract]   [Full Text] [Related]  

  • 6. [A new sulfonamide with hypoglycemic action; N-(4-isopropoxy-benzoyl) sulfanilamide; preliminary note].
    GARCIA-BLANCO J; ANTON V
    Rev Esp Fisiol; 1958 Mar; 14(1):17-20. PubMed ID: 13579526
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental animal studies on the mechanism of action of peroral antidiabetic substances and pancreatic function by means of zinc radioisotope Zn-65].
    DERMAN H
    Z Gesamte Exp Med; 1960; 133():322-7. PubMed ID: 13722054
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of diabetes mellitus with sulfanilamide preparations].
    MOSKOVICH EG; STARKOVA NI
    Sov Med; 1958 Jul; 22(7):34-42. PubMed ID: 13603000
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical result of use of sulfanilamide preparations for treatment of diabetes mellitus].
    VOGRALIK MV
    Klin Med (Mosk); 1958 Oct; 36(10):87-93. PubMed ID: 13612008
    [No Abstract]   [Full Text] [Related]  

  • 10. [Indications and contraindications for treatment of patients with diabetes mellitus with sulfanilamide preparations].
    GENES SG
    Klin Med (Mosk); 1961 Jun; 39():17-27. PubMed ID: 13704354
    [No Abstract]   [Full Text] [Related]  

  • 11. [THE INDICATIONS FOR USE AND THE EFFECTIVENESS OF SULFANILAMIDE PREPARATIONS IN DIABETES MELLITUS].
    GUSMAN SM; ALEKPEROV MA
    Sov Med; 1963 May; 26():13-8. PubMed ID: 14073318
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative assessment of cell mechanisms of the antidiabetic action of a new organic derivative of oxovanadium(IV) and vanadyl sulfate].
    Aleeva GN; Kiiasov AP; Burykin IM; Khafiz'ianova RKh
    Eksp Klin Farmakol; 2004; 67(3):42-4. PubMed ID: 15341067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of action of oral hypoglycemic preparations (BZ-55 & D-860)].
    BEHAR S
    Hospital (Rio J); 1958 Aug; 54(2):231-5. PubMed ID: 13586736
    [No Abstract]   [Full Text] [Related]  

  • 14. [Analysis of some features observed during the treatment of diabetes associated with endocrine diseases with antidiabetic sulfonylurea preparations].
    ANDREEV D
    Suvr Med (Sofiia); 1961; 12(10)():59-69. PubMed ID: 14013005
    [No Abstract]   [Full Text] [Related]  

  • 15. [Unconventional antidiabetic agents].
    Rustenbeck I
    Med Monatsschr Pharm; 2007 Apr; 30(4):131-7. PubMed ID: 17484443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oral antidiabetic agents. The mode of action of sulphonylureas.
    ACHELIS JD; MAIWALD KH
    Anglo Ger Med Rev; 1962 Jun; 1():310-33. PubMed ID: 14010843
    [No Abstract]   [Full Text] [Related]  

  • 17. Variation in antidiabetic medication intensity among Medicare beneficiaries with diabetes mellitus.
    Stuart B; Shaffer TJ; Simoni-Wastila LJ; Zuckerman IH; Quinn CC
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):195-208. PubMed ID: 17996659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANTI-CATALASE AND THE MECHANISM OF SULFANILAMIDE ACTION.
    Locke A; Main ER; Mellon RR
    Science; 1938 Dec; 88(2296):620-1. PubMed ID: 17788576
    [No Abstract]   [Full Text] [Related]  

  • 19. Antidiabetic activity of Caesalpinia bonducella seed extracts in rats.
    Kannur DM; Hukkeri VI; Akki KS
    Fitoterapia; 2006 Dec; 77(7-8):546-9. PubMed ID: 16905279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidiabetic effect of Olea europaea L. in normal and diabetic rats.
    Eidi A; Eidi M; Darzi R
    Phytother Res; 2009 Mar; 23(3):347-50. PubMed ID: 18844257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.